You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

Ascent Pharms Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ASCENT PHARMS INC, and what generic and branded alternatives to ASCENT PHARMS INC drugs are available?

ASCENT PHARMS INC has forty-one approved drugs.

Summary for Ascent Pharms Inc

US Patents:	0
Tradenames:	31
Ingredients:	31
NDAs:	41

Drugs and US Patents for Ascent Pharms Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ascent Pharms Inc	PALIPERIDONE	paliperidone	TABLET, EXTENDED RELEASE;ORAL	216174-003	Aug 23, 2023	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Ascent Pharms Inc	METHYLPHENIDATE HYDROCHLORIDE	methylphenidate hydrochloride	TABLET, EXTENDED RELEASE;ORAL	211009-004	Sep 3, 2019	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Ascent Pharms Inc	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	207419-001	Mar 22, 2017	AA	RX	No	No		⤷ Subscribe				⤷ Subscribe
Ascent Pharms Inc	MELOXICAM	meloxicam	TABLET;ORAL	217579-002	Jun 7, 2023	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Ascent Pharms Inc	LISINOPRIL	lisinopril	TABLET;ORAL	075903-006	Jul 1, 2002	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Ascent Pharms Inc	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	CAPSULE, EXTENDED RELEASE;ORAL	214959-005	Sep 29, 2021	AB1	RX	No	No		⤷ Subscribe				⤷ Subscribe
Ascent Pharms Inc	METHYLPHENIDATE HYDROCHLORIDE	methylphenidate hydrochloride	TABLET, EXTENDED RELEASE;ORAL	211009-001	Sep 3, 2019	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for ASCENT PHARMS INC drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.